• Rejuvenate Biomed secures EUR 3.2 million series A round to advance development of healthy aging products

    Tuesday March 2nd 2021

  • European Centre for Disease Prevention and Control (ECDC) intensifies the identification and tracking of mutations of the SARSCoV-2 genome across Europe with support of Eurofins Genomics

    Friday February 26th 2021

  • AbolerIS Pharma strengthens management team to support next phases of growth

    Friday February 26th 2021

  • Sarcura and imec to collaborate on high throughput cytometry solution for automated (T-)cell separation

    Thursday February 25th 2021

  • Newton Biocapital invests in Flemish start-up DeuterOncology

    Wednesday February 24th 2021

  • Preventieve speekseltest voor het opsporen van het COVID-19 virus is nu beschikbaar voor bedrijven en organisaties

    Tuesday February 23rd 2021

  • icometrix breidt icobrain portfolio uit met software voor ischemische beroerte

    Tuesday February 23rd 2021

  • BioLizard launches BioReflect scientific literature search platform

    Friday February 19th 2021

  • Your news here?

  • QBD leerstoel voor precision oncology research in glioblastoma

    Wednesday February 17th 2021

  • From SIMPLER cohorts, Eurofins Genomics successfully extracted 38.000 samples and run 40.500 samples on GWAS microarray during a one-year period.

    Monday February 15th 2021

  • Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF

    Thursday February 11th 2021

Strategic Partners